CBRE will provide real estate services for Novartis International AG, a pharmaceutical company.
CBRE's Global Workplace Solutions (GWS) and Advisory & Transaction Services teams will deliver a full suite of real estate and facilities services to the global pharmaceutical company's portfolio spanning 70 million square feet (6.5 million square meters) portfolio across more than 90 countries and multiple property types, including office, laboratory, manufacturing and research facilities.
CBRE will support Novartis in the transformation of its real estate portfolio, improving its employee workplace experience and driving its sustainability agenda.
Paul Saville-King, president at CBRE Enterprise Accounts, EMEA, said Novartis would also be reducing the environmental impact of its occupancy to "transform its workplace experience, enabling its employees to do their best work for the patients who depend on Novartis every day".